Trading Members of the Exchange are hereby informed that effective from Tuesday, December 5, 2017, the equity shares of Aspira Pathlab & Diagnostics Limited are listed and admitted to dealings on the Exchange in the list of XT Group. Further in terms of SEBI circular No. CIR/MRD/DP/02/2012 dated January 20, 2012, the scrip will be in Trade-for-Trade segment for 10 trading days.
|
Name of the company
|
Securities
|
Market Lot
|
Scrip Code
|
|
Aspira Pathlab & Diagnostics Limited
|
51,93,000 Equity shares of Face Value of Rs. 10 /- each fully paid-up.
Distinctive numbers:
1 to 51,93,000*
|
One Share
|
540788
|
|
Registered Office Address:
|
Abbreviated Name on BOLT Plus System
|
Scrip ID on BOLT Plus System
|
ISIN No.
|
|
Address:
Flat No. 2, R.D. Shah Building,
Shraddhanand Road, Opposite Ghatkopar Railway Station,
Ghatkopar (West) Mumbai- 400086
Website-www.aspiradiagnostics.com
Email ID for Investor Grievances:
info@aspiradiagnostics.com
|
ASPIRA
|
ASPIRA
|
INE500C01017
|
*12,31,000 Equity Shares held by Promoters are to be kept under lock in up to December 31, 2020 and 14,95,800 Equity Shares held by Promoters are to be kept under lock in up to January 01, 2021
1. Trading Members may note that as per the guidelines issued by SEBI dated 16th February, 2000, securities of the company will only be traded in Dematerialised form. Trades effected in this scrip will be in unit market lot (i.e. one share).
2. The Trading Members may please note that the above mentioned scrip will be a part of Special Pre-open Session (SPOS) for IPO’s & Relisted Scrips - Relist session on Tuesday, December 5, 2017.
For further information on SPOS, the Trading Members are requested to refer to the Exchange’s notice no. 20120216-29 on Enabling Special Pre-open Session for IPO’s & Relisted Scrips.
For any clarification on the above, the Trading Members may please contact the Helpdesk on 022-6136 3100 / 6136 3171.
3. Trading Members are further requested to note that dealing in the above mentioned scrip of the Company will be allowed only under “Periodic Call Auction System” (PCAS), with applicable price band till the Company meets the Main Board norms of the Exchange.
For further information on Periodic Call Auction System (PCAS), the Trading Members are requested to refer SEBI circular no CIR/MRD/DP/38/2013 dated December 19, 2013 and Exchange Notice No-20131220-26 dated December 20, 2013.
4. The Equity shares of the company are listed at Calcutta Stock Exchange Limited and Metropolitan Stock Exchange Limited.
5. The unaudited financial result of the Company for the Quarter-ended September 30, 2017 is enclosed as Annexure I.
6. A copy of the Shareholding Pattern as on November 29, 2017, as submitted by the company, is enclosed as Annexure II.
7. Copy of Annual Report for the Year ended 2016-2017 is enclosed as Annexure III.
8. The Company’s financial year ending is March 31.
9. The Company Profile containing all the information about the company can be viewed at www.bseindia.com/corporates/direct_list.aspx?expandable=1
10. The address of the Registrar and Transfer Agent of the Company is given below:
NICHE TECHNOLOGIES PRIVATE LIMITED
D-511, Bagree Market, 5Th Floor
71, B.R.B.Basu. Road
Kolkata – 700001
Tel : 033 – 22357271 / 7270
In case Trading Members require any clarifications on the subject matter of this Notice, they may please contact any of the following:
|
A) At the company:
Ms. Snehal Sawant
(Company Secretary & Compliance
Officer)
Tel : 022 – 62166800
Email ID:
cssnehalsawant@gmail.com
|
Registered Office Address:-
Flat No. 2, R.D. Shah Building,
Shraddhanand Road, Opposite Ghatkopar Railway Station, Ghatkopar (West) Mumbai- 400086
Phone : 022-71975756/71975656
Website- www.aspiradiagnostics.com
|
|
B) At the Exchange:
Mr. Atul Dhotre
Senior Manager – Listing
|
Tel. No.: +91-22-22728934
|
For BSE Ltd.,
Bhushan Mokashi Atul Dhotre
Additional General Manager Senior Manager
Friday, December 1, 2017
Encl: a/a |